secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2026-06-02T19:35:05+00:00
Accession:  0001140361-26-023698
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech regains Nasdaq minimum bid price compliance as of June 2, 2026
--------------------------------------------------------------------------

- Nasdaq notified PDS Biotech on June 2, 2026 that it regained compliance with the $1.00 minimum bid price rule.
- The company had fallen below $1.00 for 30 consecutive business days, triggering a deficiency letter on Feb 25, 2026.
- Nasdaq has closed the matter; no further compliance actions required for this issue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/0001140361-26-023698-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/ef20075449_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-023698

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer